clinical trial · NCT06036784
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
Postbariatric HypoglycemiaMBX 1416 (Part A)MBX 1416 (Part B)PlaceboMBX 1416 (Part C)
brief summary
The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses and Drug Drug Interaction of MBX 1416 in healthy volunteers This study includes 3 parts. Part A involves a single dose of MBX 1416 or placebo taken as a subcutaneous injection (SC). Part B involves repeat doses of MBX 1416 or placebo taken as a subcutaneous injection (SC). Part C involves the evaluation of rosuvastatin and acetaminophen pharmacokinetics in the presence and absence of MBX 1416.
started
Sep 18, 2023
primary completion
Nov 14, 2024
completion
Dec 5, 2024
last updated
Dec 12, 2024
official title
A Phase 1 Single and Multiple Ascending Dose and Drug Drug Interaction Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol